Alaunos Therapeutics (TCRT)
(Delayed Data from NSDQ)
$3.02 USD
+0.28 (10.22%)
Updated Aug 4, 2025 03:54 PM ET
After-Market: $3.00 -0.02 (-0.66%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Alaunos Therapeutics, Inc. has a market cap of $4.49M, which represents its share price of $2.74 multiplied by its outstanding shares number of 1.64M. As a small-cap company, TCRT's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
TCRT 3.02 +0.28(10.22%)
Will TCRT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TCRT based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for TCRT
Alaunos Therapeutics Raises $850,000 in Private Offering
Alaunos Therapeutics Closes Registered Direct Offering
Alaunos Therapeutics (TCRT) Secures $2 Million from Stock Offering | TCRT Stock News
Alaunos prices 610,399 shares at $3.36 in registered direct offering
Alaunos Therapeutics (TCRT) Stock Declines Following $2M Equity Offering